Search

everythinglearnresearchcommunity

for

Search:↓

Nanoparticles may improve caffeine delivery for hair growth, offering a potential alternative to minoxidil for hair loss treatment.

Sun exposure and corticosteroid use are linked to a skin condition, aseptic necrosis can happen with different wart treatments, and hair loss might be caused by hormone injections and dieting.

The 2003 consensus updated PCOS diagnosis criteria and linked PCOS to higher risks of diabetes and heart problems, recommending lifestyle changes to lower these risks.

Nanoparticles can improve skin treatments by better targeting hair follicles, but more research is needed for advancement.

Mouflon rams mature gradually with changes in body, horns, and hormones linked to age and seasons, reaching full sexual maturity well after puberty.

Minoxidil affects cell growth in two ways: low doses increase growth, while high doses slow it down and can be toxic.

Hair disorders are caused by a complex mix of biology, genetics, hormones, and environmental factors, affecting hair growth and leading to conditions like alopecia.

The study found that women with hyperandrogenic PCOS have higher levels of AKT1 and AKT2 proteins in their cells, which may lead to cell dysfunction.

Hair greying is linked to reduced ATM protein in hair cells, which protects against stress and damage.

Transvaginal hydrolaparoscopy is effective for increasing ovulation and pregnancy rates in women with PCOS who didn't respond to clomiphene.

Finasteride-loaded ethosomes improve hair loss treatment by targeting pilosebaceous unit.

Nanoparticles can be used to deliver drugs to hair follicles, potentially improving treatments for conditions like acne and alopecia, and could also be used for vaccine delivery and gene therapy.

Bimatoprost is more effective than sweet almond oil for enhancing eyebrow growth.

Male hormones, particularly DHT, are linked to male pattern hair loss, and treatments like finasteride can help, but they don't work for postmenopausal women's hair loss, which may have different causes.

GABRA2 gene variations impact alcohol response, and hair loss medication finasteride reduces some effects.

There are many treatments for permanent hair loss disorders, but their effectiveness varies and there's no clear best option.

Treatments for permanent hair loss from scarring aim to stop further loss, not regrow hair, and vary by condition, with partial success common.

Traction alopecia is more common in African women than girls, especially when traction is applied to chemically relaxed hair; avoiding such hairstyles may reduce the risk.

Polygonum multiflorum extract helps grow hair by activating certain hair growth signals in mice.

The conclusion is that certain scalp tissue changes are characteristic of lichen planopilaris, with mucinous perifollicular fibroplasia being a new feature for diagnosis.

Mycophenolate mofetil was effective for most patients in treating scarring hair loss, but some had side effects.

Dutasteride-containing mesotherapy effectively treats female hair loss, improving density and thickness with minimal side effects.

New cells are added to the hair's dermal papilla during the active growth phase.

Trichoscopy is a useful tool for diagnosing hair disorders without pulling out hair.

The hair shedding scale accurately identifies abnormal hair shedding in women with long hair, with grades 5 and 6 indicating excessive shedding.

Caffeine applied to the scalp can protect hair follicles from UV damage.

Women with PCOS have higher levels of AMH in their blood and follicles, and this can help predict their risk of overreaction to fertility treatments.

Choosing hair follicles at the same growth stage leads to more consistent hair growth experiments.

Platelet-rich plasma treatment for non-scarring hair loss shows mixed results and needs more research.

Blocking SCD1 in the skin with XEN103 shrinks sebaceous glands in mice.